Jessica Donington to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Jessica Donington has written about Chemotherapy, Adjuvant.
Connection Strength
0.883
-
Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 06; 165(6):1949-1953.
Score: 0.195
-
Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Ann Thorac Surg. 2023 06; 115(6):1544-1555.
Score: 0.194
-
Surgical Issues for Operable Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2022 02 20; 40(6):530-538.
Score: 0.185
-
Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery. J Thorac Cardiovasc Surg. 2019 07; 158(1):287-288.
Score: 0.153
-
Management of the Apical Tumor: May 4, 2013, Minneapolis, MN. Semin Thorac Cardiovasc Surg. 2013; 25(3):256-71.
Score: 0.104
-
Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003 Oct; 24(4):631-6; discussion 636-7.
Score: 0.052